Skip to content

Prospective, randomized controlled clinical trial on the efficacy of ADHD cognitive-behavioral therapy computer system in children with attention deficit hyperactivity disorder

Transformation and popularization of computer system for cognitive-behavioral treatment of attention deficit hyperactivity disorder in children

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094181
Enrollment
Unknown
Registered
2024-12-18
Start date
2024-12-20
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

experimental group:Computer cognitive-behavioral therapy
control group:After 8 weeks, computer or medication treatment will be given according to the wishes of the parents and the subjects themselves.

Sponsors

Ningxia Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Meets the diagnostic criteria for ADHD in DSM-V; No family history of mental illness; Age and sex were matched with children in ADHD group; The total IQ score of Wechsler children intelligence test is >=70 points; The participating children and their guardians sign informed consent after fully understanding the study content, indicating their voluntary participation in the study; The subjects had no color vision impairment, were right-handed and had normal hearing, and were able to cooperate for subsequent treatment evaluation; During the six months prior to joining the study, participants had not received any psychiatric medication or other interventions.

Exclusion criteria

Exclusion criteria: suffering from a serious physical disease; suffering from various developmental disorders such as mental retardation and loneliness spectrum disorder; suffering from schizophrenia, bipolar disorder, depression and other serious mental illness; Patients with neurological disorders, severe brain trauma and cerebrovascular diseases; Patients with substance dependence or alcohol dependence; If there are other serious physical disabilities or unable to understand the training content, it is difficult to operate the computer or participate in the training.

Design outcomes

Secondary

MeasureTime frame
executive function;social function;cognitive function;mental health and emotional status;clinical symptoms;HRV;sleep detection;Catecholamines;oxytocin;cortisol;adverse reaction;serotonin;galvanic skin response;

Primary

MeasureTime frame
therapeutic efficacy;

Countries

China

Contacts

Public ContactFang Jianqun

Ningxia Medical University General Hospital

fjq7887215@163.com+86 951 674 3759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026